Deletion of the alpha-globin gene cluster as a cause of acquired alpha-thalassemia in myelodysplastic syndrome
- PMID: 14576055
- DOI: 10.1182/blood-2003-09-3222
Deletion of the alpha-globin gene cluster as a cause of acquired alpha-thalassemia in myelodysplastic syndrome
Abstract
Rarely, myelodysplastic syndrome (MDS) is complicated by an acquired form of alpha-thalassemia (alpha-thalassemia in myelodysplastic syndrome [ATMDS]) characterized by hypochromic, microcytic, anisopoikilocytic red blood cells with hemoglobin H (HbH) inclusions. Acquired mutations in ATRX, a chromatin remodeling gene, have recently been found in 12 patients with typical features of ATMDS, though they have not been detected in MDS patients with similar red blood cell findings but little HbH. The alpha-globin genes themselves have appeared normal in all ATMDS patients studied to date. Here we characterize the molecular defect in a unique MDS patient with rare HbH inclusions in which an abnormal clone lost a greater than 1.9-Mb segment of the telomeric region of the short arm of one allele of chromosome 16, including both alpha-globin genes. Red blood cell changes associated with this acquired somatic genotype (--/alpha alpha) are surprisingly severe, demonstrating that a minor globin chain imbalance may be unexpectedly deleterious during the abnormal erythropoiesis that occurs in the context of MDS.
Similar articles
-
Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations.Blood. 2004 Mar 15;103(6):2019-26. doi: 10.1182/blood-2003-09-3360. Epub 2003 Oct 30. Blood. 2004. PMID: 14592816
-
A novel 5' ATRX mutation with splicing consequences in acquired alpha thalassemia-myelodysplastic syndrome.Haematologica. 2005 Nov;90(11):1463-70. Haematologica. 2005. PMID: 16266892
-
Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies.Blood. 2005 Jan 15;105(2):443-52. doi: 10.1182/blood-2004-07-2792. Epub 2004 Sep 9. Blood. 2005. PMID: 15358626 Review.
-
A new ATRX mutation in a patient with acquired α-thalassemia myelodysplastic syndrome.Hemoglobin. 2012;36(6):581-5. doi: 10.3109/03630269.2012.724040. Epub 2012 Oct 24. Hemoglobin. 2012. PMID: 23092150
-
De novo and acquired forms of alpha thalassemia.Curr Hematol Rep. 2006 Mar;5(1):11-4. Curr Hematol Rep. 2006. PMID: 16537041 Review.
Cited by
-
α-Thalassemia, mental retardation, and myelodysplastic syndrome.Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a011759. doi: 10.1101/cshperspect.a011759. Cold Spring Harb Perspect Med. 2012. PMID: 23028133 Free PMC article.
-
Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.J Neurooncol. 2018 Jan;136(2):223-231. doi: 10.1007/s11060-017-2676-5. Epub 2017 Dec 1. J Neurooncol. 2018. PMID: 29196926 Review.
-
Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies.PLoS Genet. 2019 Apr 10;15(4):e1008039. doi: 10.1371/journal.pgen.1008039. eCollection 2019 Apr. PLoS Genet. 2019. PMID: 30970016 Free PMC article.
-
Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.Drugs. 2011 Jan 22;71(2):155-77. doi: 10.2165/11585280-000000000-00000. Drugs. 2011. PMID: 21275444 Review.
-
The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer.Cancers (Basel). 2023 Apr 10;15(8):2228. doi: 10.3390/cancers15082228. Cancers (Basel). 2023. PMID: 37190157 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous